Investor Intelligence
Stop wasting time researching the wrong investors
Early-stage life sciences founders lose hundreds of hours to investor research that goes nowhere. We built the system that identifies the right investors for your exact raise and the outreach infrastructure to get in front of them.
Join the WaitlistEarly access is limited.
Your science is ready, your investor pipeline probably isn't
Most life sciences founders come from research environments where commercialization infrastructure didn't exist. At this stage, that gap starts to cost real money.
You're targeting the wrong funds
Stage, therapeutic focus, check size, geography. Most investor lists are assembled by hand and miss key filters. The result is outreach that hits all the wrong doors.
The list is only half the problem
Other platforms will give you a ranked list of investors whose thesis aligns with your venture. That is useful. What they won't do is build the outreach infrastructure that actually puts you in front of those people.
Follow-up is where raises are lost
A warm introduction goes cold in 72 hours if there's no system behind it. Most founders know this and still let it happen because there are seventeen other things on the priority list.
Legacy data is expensive and stale
The enterprise databases cost $30,000 a year or more. They were built for firms with dedicated analysts. Early-stage founders pay for access they can't operationalize and data that doesn't update fast enough to matter.
"I've talked to biotech founders who had 300 investors in a spreadsheet. Not a CRM, an actual Excel file, with communication notes jammed into a single cell that kept expanding downward. They were doing their review every few months, scrolling through, trying to remember who said check back in six months and when that was. Color coding rows. Bold text on the urgent ones. At some point the system stops working and they know it, but switching feels like it costs more time than staying stuck. That's the window where raises get lost."
— Christopher Wilson, Founder, MedAxis AI
Not just a list, a complete outreach system
Investor Intelligence combines AI-powered targeting with the outreach infrastructure to act on it. The intelligence and the execution live in the same system.
What Other Platforms Give You
What Investor Intelligence Delivers
A curated list of investors whose thesis aligns with your stage and focus
AI-powered investor matching on stage, thesis, therapeutic focus, and geography
Static data you have to act on manually
Data refreshed regularly from primary sources, not quarterly exports
No outreach support. You still cold-email yourself.
Automated outreach built for founder-led raises. Professional follow-up without needing an investor relations team.
Pricing built for enterprise teams with dedicated analysts
Priced for founders, not analysts. A fraction of legacy database costs.
Software with no commercial motion behind it
Built by a team that has run commercial motions inside life sciences companies
Start from scratch. Your existing work does not carry over.
Starts from your existing investor list. Scores it, enriches it, and builds on what you already have.
From scattered research to working pipeline
Build your investor pipeline without manual research, cold lists, or guesswork. Just the right investors and a system to reach them.
Profile your raise
You tell us your stage, therapeutic focus, indication, geography, and funding target. The system builds your investor match criteria and filters the universe of funds down to the ones worth your time. Still finalizing your funding target? Funding Mix Calculator.
Get a verified target list
Investor Intelligence delivers a scored, verified list of funds and decision-makers aligned with your profile. No noise. Each contact is verified and enriched with the context you need to open the right doors.
Activate the outreach system
Unlike platforms that stop at the list, Investor Intelligence connects directly to an outreach system. Sequences, follow-ups, and reply tracking built in. Your pipeline runs while you focus on your science.
Not sure how much equity to raise? Model your funding mix first.
Before you go after investors, you need to know what your raise actually looks like. Our free Funding Mix Calculator helps life sciences founders model grants, tax credits, and equity together — so you can see dilution, runway, and founder ownership before you talk to a single fund. Supports US, Canadian, UK, and European non-equity funding contexts.
- Combine non-dilutive funding with equity in one model
- See real-time dilution and post-money cap table impact
- Plan runway across multiple funding sources
Free. No signup required.
Get early access before the public
We're onboarding a small group of life sciences founders to refine the product before broad release. If you're currently raising or preparing to raise in the next 12 months, this was built for you.
Reserve My SpotNo commitment required. We'll reach out to learn about your raise and determine eligibility for access.